WGC
PDSB icon

Watts Gwilliam & Co’s PDS Biotechnology PDSB Stock Holding History

Watts Gwilliam & Co’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$55.5K Hold
55,000
– – 0.01% 223
2025
Q2 		$63.3K Buy
+55,000
New +$74.7K 0.01% 220

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Watts Gwilliam & Co's PDSB Position: Q3 2025 in Review

Watts Gwilliam & Co held its PDS Biotechnology (PDSB) position steady in Q3 2025 at 55,000 shares worth $55.5K. The position accounts for 0.01% of the portfolio, ranked #223.

Watts Gwilliam & Co first reported a position in PDSB in Q2 2025 and has held it in 2 quarters since. The position peaked at $63.3K in Q2 2025. 47 funds tracked by Wall St. Rank hold PDSB as of Q3 2025.

  • Watts Gwilliam & Co held 55,000 shares of PDS Biotechnology worth $55.5K as of Q3 2025.
  • Watts Gwilliam & Co left its PDS Biotechnology share count unchanged in Q3 2025.
  • PDS Biotechnology made up 0.01% of Watts Gwilliam & Co's portfolio in Q3 2025, its #223 holding.
  • Watts Gwilliam & Co first reported a position in PDS Biotechnology in Q2 2025 and has held it in 2 quarters since.
  • Watts Gwilliam & Co's PDS Biotechnology position peaked at $63.3K in Q2 2025.
  • 47 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2025.

Based on Watts Gwilliam & Co's 13F filing for Q3 2025, filed 21 Nov 2025.